EVAH Announces the Nomination of Frédéric Leduc as Chief Scientific Officer

The organization is adding a strategic member to its growing team.

Montréal, Québec, June 30, 2022 – EVAH Corp. is proud to announce the nomination of Frédéric Leduc as the company’s Chief Scientific Officer, once again demonstrating EVAH’s ability to attract experienced talent to its team. The company has grown steadily over the last year and now counts 25 employees, 70% of whom is scientific staff.

I’m extremely proud to be joining EVAH Corp. and contributing to their mission of fostering innovations for animal health that have a global reach and the goal of sustainability,” Leduc says. “We have a unique and tremendous opportunity, in the short term, to improve worldwide health while reducing the use of antibiotics and the environmental impact of food production,” he adds. 

An impressive background

Frédéric Leduc has a truly remarkable professional and academic background. He is an active member of the scientific, biochemistry, business and environmental communities. As one example, since 2016 he has been on the board of directors at BIOQuébec, a non-profit organization representing the interests of Québec’s biotechnology and life sciences industry. His peers recently elected him chair of the organization’s board.

EVAH’s new Chief Scientific Officer is also an experienced businessman. He co-founded Immune Biosolutions, an innovative biotechnology company based in Québec. There, he was CEO for nearly a decade, where he secured the organization’s funding and built key partnerships in the development of new immunotherapy treatments in oncology and infectious diseases.

Leduc has a PhD in Biochemistry from Université de Sherbrooke, and has completed various academic and professional courses in business and leadership. He has received many prizes and awards, including a Youth Entrepreneurship Grand Prize from the OSEntreprendre Challenge.

Frédéric is remarkably curious and proactive. These are critical qualities in our industry, where you always have to think ahead and grow with change. This is just one reason we’re confident that he will make an important contribution to EVAH,” says Michel Fortin, CEO at EVAH Corp. “He’s both a trained scientist and an experienced businessman. Both of these hats make him the ideal candidate to further EVAH’s unique business model,” he adds.

About EVAH Corp. 

Evolution in Animal Health (EVAH) is innovating for a better tomorrow. We are a Canada-based biotechnology company with a global perspective. Our team of managers and scientists is acquiring and developing animal health technologies and collaborating with research and development experts to bring them to the pre-commercial stage. We are positioned to respond to global trends in the food-producing animal space and tap growing markets for productivity-enhancing solutions to sustainably feed the world thanks to healthy animal production and address consumer needs for non-antibiotic protein.

– 30 –

Media relations: 

Anaïs Blanchard
MERCURE Consulting Group